Taking Stock
OPKO's Bishop on FDA Approval Of Its Kidney Disease Drug(Audio)
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:08:45
- More information
Informações:
Synopsis
(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Dr. Charles Bishop, CEO of OPKO Health Renal Division, to discuss the FDA’s approval of Rayaldee and the health issues surrounding chronic kidney disease
